You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Scheller discussed with GenomeWeb why he joined 23andMe after leaving Genentech and his plans for the new therapeutics division.
The consumer genomics firm has created a therapeutics group headed up by former Genentech executive Richard Scheller.
The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.
Genentech and 23andMe aim to advance Parkinson's drug research by sequencing the largest number of people to date.
Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.
Toshiba has the exclusive right to provide genotyping services on the Japonica Array to Japanese universities, hospitals, pharmaceutical companies, and other research organizations.
The FDA's regulation of lab tests and devices used in clincial investigations is impacting federally funded study protocols involving advanced sequencing tests.
For the time being, the company doesn't expect to run into regulatory trouble in the UK.
The Clinical Genome Resource has launched GenomeConnect, an online portal for patients to voluntarily contribute their de-identified genotypic and phenotypic information to publicly available genomic databases.
NEW YORK (GenomeWeb) – Scientists from consumer genomics firm 23andMe for the first time described the Mountain View, Calif.-based company's Ancestry Composition tool in a paper.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.